April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Hyperreflective Intraretinal Spots in Radiation Maculopathy: an in vivo Spectral Domain OCT Study
Author Affiliations & Notes
  • Giulia Midena
    University Campus Bio-Medico, Roma, Italy
  • Raffaele Parrozzani
    GB Bietti Foundation, IRCCS, Roma, Italy
  • Luisa Frizziero
    Ophthalmology, University of Padova, Padova, Italy
  • Stela Vujosevic
    Ophthalmology, University of Padova, Padova, Italy
  • Elisabetta Pilotto
    Ophthalmology, University of Padova, Padova, Italy
  • Edoardo Midena
    GB Bietti Foundation, IRCCS, Roma, Italy
    Ophthalmology, University of Padova, Padova, Italy
  • Footnotes
    Commercial Relationships Giulia Midena, None; Raffaele Parrozzani, None; Luisa Frizziero, None; Stela Vujosevic, None; Elisabetta Pilotto, None; Edoardo Midena, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5952. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Giulia Midena, Raffaele Parrozzani, Luisa Frizziero, Stela Vujosevic, Elisabetta Pilotto, Edoardo Midena; Hyperreflective Intraretinal Spots in Radiation Maculopathy: an in vivo Spectral Domain OCT Study. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5952.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To evaluate in vivo the presence of intraretinal hyperreflective spots in eyes with radiation induced maculopathy.

Methods: 25 subjects affected by maculopathy secondary to eye irradiation for a primary intraocular uveal melanoma were enrolled. Diabetic retinopathy, retinal vascular disorders, intraocular inflammation and previous treatment with any intraocular drug were the main exclusion criteria. All eyes previously underwent Iodine125 brachytherapy with a standard apex dose (85 Gy at tumor apex). Macula was never directly included in the irradiation field. Full ophthalmic examination, including spectral domain-OCT (SD-OCT) and fluorescein angiography, was performed in all eyes. After segmentation of retinal layers by SD-OCT, retinal images were analyzed for reflectivity changes (hyperreflectivity spots) at the level of: internal limiting membrane plus retinal nerve fiber layer (ILM+RNFL), inner nuclear layer plus outer plexiform layer (INL+OPL) and outer nuclear layer (ONL). Hyperreflective spots were analyzed in a full retinal section both in the foveal area, and between 500 and 1500 µm from the foveal center. All examinations were performed twice, by two independent masked graders.

Results: The inter-grader agreement was at least substantial for all measurements. In all studied eyes hyperreflective spots were detected by SD-OCT. Hyperreflective spots were mainly located in the inner retina (ILM+RNFL and INL+OPL) compared to the outer retina (ONL) (p<0.005), and their expression significantly progressed with the progression of macular (radiation induced) edema (p= 0.002).

Conclusions: The presence of retinal discrete microaggregates appearing, on SD-OCT, as hyperreflective spots may represent an in vivo biomarker of retinal microglia activation in radiation maculopathy, as previoulsy shown in other macular disorders. The increase in number and the migration toward outer retinal layers of the (hyperreflective) microaggregates mirrors more severe stages of maculopathy, and confirms the importance of neuroinflammation in the development and progression of radiation-induced maculopathy. This aspect may be related to the so-called senescence process induced by irradiation of solid (intraocular) tumors. This phaenomenon may offer more tailored approaches for the treatment of radiation induced maculopathy.

Keywords: 585 macula/fovea • 671 radiation therapy • 595 microglia  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×